Alloy vs Remi Meds
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
Remi Meds
Best for Buyers wanting a per-dose-tier compounded-GLP-1 platform with a NAMED compounding pharmacy partner (Strive Pharmacy, Gilbert AZ) and explicit 503A compliance language, who can accept a third-party clinical-network model (Beluga Health) and no public per-state availability list.Starting at $249/mo
Side-by-Side Comparison
| Feature | Alloy | Remi Meds |
|---|---|---|
| Overall Score | ✓7.4/10 | 5.5/10 |
| Starting Price | ✓$80/mo | $249/mo |
| Editorial Rating | ✓3.7 ★ /5 | 2.8 ★ /5 |
| Features | 8 features | ✓10 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
Remi Meds
Pros
- ✓**Named compounding pharmacy** (Strive Pharmacy, Gilbert AZ) — stronger transparency than peers who only say ‘503A pharmacies’
- ✓**LegitScript verification badge** present on homepage
- ✓**Verbatim 503A FDCA compliance language** on tirzepatide product page
- ✓**Per-dose-tier pricing fully surfaced** (no ‘as low as’ floor-only obfuscation)
- ✓Operating corporate entity disclosed (T-C HEALTH CO, California dba)
- ✓Does NOT sell retatrutide (compliant with FDA Sept 2025 enforcement landscape)
- ✓Clear non-affiliation disclaimer re: Wegovy/Ozempic/Mounjaro/Saxenda/Victoza trademarks
Cons
- ✗**No named medical leadership** — no Medical Director, founder, or physician disclosed on any public page
- ✗**States served NOT enumerated** — ‘nationwide’ claim with no per-state list
- ✗**Third-party clinical network (Beluga Health)** flagged in March 2026 StatNews analysis as one of four medical groups affiliated with 30%+ of FDA-warned GLP-1 telehealth companies (Remi Meds itself NOT named in any FDA warning letter)
- ✗**Year founded / corporate history opaque**
- ✗Two different phone numbers and a secondary email (info@rekindlerx.com) hint at affiliated ‘Rekindle RX’ brand sharing infrastructure
- ✗Mailing address (Leesburg FL) does not match operating-entity state (California)
- ✗No SOC 2 claim; HIPAA Notice present but no third-party attestation
Our Verdict
Alloy edges out Remi Meds with a higher overall score of 7.4/10 and is particularly strong for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory. Remi Meds remains a solid alternative, especially if you're looking for Buyers wanting a per-dose-tier compounded-GLP-1 platform with a NAMED compounding pharmacy partner (Strive Pharmacy, Gilbert AZ) and explicit 503A compliance language, who can accept a third-party clinical-network model (Beluga Health) and no public per-state availability list..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.